Global Editions

The Oxford/AstraZeneca vaccine will be tested in a new trial after questions over its data

It's hoping to assuage concerns over the way it collected and presented its data so far.
by Charlotte Jee

The news: The Oxford University/AstraZeneca vaccine will be tested in a new global trial, AstraZeneca’s CEO, Pascal Soriot, has told Bloomberg. Previously it had been expected to just add an arm to its existing US trial. The news comes amid criticism of the way it has collected and presented its data so far.

Read more on technologyreview.com.

اسے اردو میں پڑھیں

Authors

*

Top